Geode Capital Management’s Neos Therapeutics, Inc NEOS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-340,768
| Closed | -$212K | – | 4508 |
|
|
2020
Q4 | $212K | Hold |
340,768
| – | – | ﹤0.01% | 3867 |
|
|
2020
Q3 | $180K | Hold |
340,768
| – | – | ﹤0.01% | 3746 |
|
|
2020
Q2 | $233K | Hold |
340,768
| – | – | ﹤0.01% | 3620 |
|
|
2020
Q1 | $255K | Sell |
340,768
-21,120
| -6% | -$29K | ﹤0.01% | 3477 |
|
|
2019
Q4 | $546K | Hold |
361,888
| – | – | ﹤0.01% | 3468 |
|
|
2019
Q3 | $535K | Buy |
361,888
+5,253
| +1% | +$8.5K | ﹤0.01% | 3451 |
|
|
2019
Q2 | $460K | Sell |
356,635
-115,956
| -25% | -$213K | ﹤0.01% | 3495 |
|
|
2019
Q1 | $1.23M | Buy |
472,591
+105,095
| +29% | +$246K | ﹤0.01% | 3075 |
|
|
2018
Q4 | $606K | Buy |
367,496
+107,627
| +41% | +$302K | ﹤0.01% | 3301 |
|
|
2018
Q3 | $1.26M | Buy |
259,869
+11,025
| +4% | +$62.5K | ﹤0.01% | 3119 |
|
|
2018
Q2 | $1.55M | Buy |
248,844
+39,330
| +19% | +$293K | ﹤0.01% | 2994 |
|
|
2018
Q1 | $1.74M | Buy |
209,514
+1,946
| +0.9% | +$18.6K | ﹤0.01% | 2840 |
|
|
2017
Q4 | $2.12M | Buy |
207,568
+31,861
| +18% | +$306K | ﹤0.01% | 2719 |
|
|
2017
Q3 | $1.61M | Buy |
175,707
+48,618
| +38% | +$369K | ﹤0.01% | 2864 |
|
|
2017
Q2 | $927K | Buy |
127,089
+34,133
| +37% | +$258K | ﹤0.01% | 3133 |
|
|
2017
Q1 | $669K | Buy |
92,956
+15,962
| +21% | +$99K | ﹤0.01% | 3198 |
|
|
2016
Q4 | $450K | Buy |
76,994
+2,613
| +4% | +$17.7K | ﹤0.01% | 3303 |
|
|
2016
Q3 | $489K | Buy |
74,381
+25,871
| +53% | +$205K | ﹤0.01% | 3258 |
|
|
2016
Q2 | $450K | Buy |
48,510
+9,812
| +25% | +$93.6K | ﹤0.01% | 3261 |
|
|
2016
Q1 | $417 | Buy |
38,698
+1,997
| +5% | +$21.1K | ﹤0.01% | 3322 |
|
|
2015
Q4 | $525K | Buy |
36,701
+90
| +0.2% | +$1.36K | ﹤0.01% | 3263 |
|
|
2015
Q3 | $769K | Buy |
+36,611
| New | +$807K | ﹤0.01% | 3027 |
|
Geode Capital Management's NEOS Position: Q1 2021 in Review
Geode Capital Management sold out of Neos Therapeutics, Inc (NEOS) in Q1 2021, closing a stake of 340,768 shares — an estimated $212K sold.
Geode Capital Management first reported a position in NEOS in Q3 2015 and held it in 22 quarters. The position peaked at $2.12M in Q4 2017. 0 funds tracked by Wall St. Rank hold NEOS as of Q1 2021.
- Geode Capital Management reported no remaining Neos Therapeutics, Inc position as of Q1 2021 after selling out during the quarter.
- Geode Capital Management sold 340,768 Neos Therapeutics, Inc shares in Q1 2021, an estimated $212K.
- Geode Capital Management first reported a position in Neos Therapeutics, Inc in Q3 2015 and held it in 22 quarters.
- Geode Capital Management's Neos Therapeutics, Inc position peaked at $2.12M in Q4 2017.
- 0 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q1 2021.
Based on Geode Capital Management's 13F filing for Q1 2021, filed 12 May 2021.